French drugmaker Sanofi and its US partner Translate Bio will kick off human Phase 1/2 clinical trials for MRT5500, its messenger RNA-based vaccine …
Shares of Novavax popped almost 23% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine candidate showed to …
Norsk Hydro ASA has clinched a €1.38 billion deal to sell its rolling business to private equity firm KPS Capital Partners, in a …
General Motors confirmed on Thursday that the vehicle maker is weighing building a second battery cell manufacturing plant in the US with joint …
The UK’s antitrust regulator has launched an investigation into Apple Inc. following complaints that the iPhone maker’s terms and conditions for software app …
Green Thumb Industries has inked an exclusive partnership to manufacture and distribute Cann’s line of cannabis-infused sparkling drinks in the US starting this …
Las Vegas Sands announced the sale of its Las Vegas real estate properties and operations, for an aggregate $6.25 billion, as the casino …
Shares of KemPharm Inc. exploded 93% in Wednesday’s pre-market trading session after the US Food and Drug Administration (FDA) approved its treatment for …
Germany’s healthcare and chemicals group Merck KGaA has inked a global licensing agreement with Debiopharm to develop and commercialize xevinapant for the treatment …
XPeng said that electric vehicle (EV) deliveries in February dropped to 2,223 due to the week-long Chinese New Year holiday. That’s after the …
